SHARE

Bridgepoint agrees $460m acquisition of clinical skincare brand Obagi Medical

The UK investment firm has agreed to acquire the clinical skincare brand from Waldencast for $460m. The acquisition expands Bridgepoint’s presence in the doctor-backed skincare sector alongside existing assets Laboratoires Vivacy and Roc.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.